← Back to Search

Insulin Pump

Closed Loop Insulin for Chronic Pancreatitis

N/A
Waitlist Available
Led By Melena Bellin, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up continuous over the 72 hour investigation period
Awards & highlights

Summary

The purpose of this study is to determine the effectiveness of closed loop insulin pump therapy to control blood sugar following total pancreatectomy and islet auto-transplantation (TPIAT).

Eligible Conditions
  • Chronic Pancreatitis
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~continuous over the 72 hour investigation period
This trial's timeline: 3 weeks for screening, Varies for treatment, and continuous over the 72 hour investigation period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Study Period: Average Serum BG
Study Period: Serum BG Standard Deviation
Secondary outcome measures
Study Period: CGM Area Under the Curve (AUC) With Glucose < 70 mg/dL
Glucose
Study Period: Continuous Glucose Monitor Standard Deviation of BG
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Closed Loop InsulinExperimental Treatment1 Intervention
Closed Loop Insulin Group: patients receive continuous subcutaneous insulin controlled by experimental closed loop system during the 72 hour study period.
Group II: ControlActive Control1 Intervention
Control Group: patients receive conventional multiple daily injection insulin therapy with basal and bolus dosing during the 72 hour study period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Closed Loop Insulin
2014
N/A
~20

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,413 Previous Clinical Trials
1,561,389 Total Patients Enrolled
Medtronic DiabetesIndustry Sponsor
67 Previous Clinical Trials
9,987 Total Patients Enrolled
Melena Bellin, MDPrincipal InvestigatorUniversity of Minnesota
2 Previous Clinical Trials
187 Total Patients Enrolled
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top